Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer

10.1038/cddis.2017.513

Saved in:

Bibliographic Details
Main Authors:	Xia H., Hui K.M.
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Nature Publishing Group 2020
Subjects:	acetylsalicylic acid chemokine clopidogrel growth arrest and DNA damage inducible protein 45 long chain fatty acid coenzyme A ligase long chain fatty acid coenzyme A ligase 4 nonsteroid antiinflammatory agent oxidoreductase protein HTATIP2 sorafenib stromal cell derived factor 1 alpha unclassified drug antineoplastic agent antineoplastic activity bleeding cancer adjuvant therapy cancer prevention cancer recurrence cancer risk chronic hepatitis B chronic liver disease disease course disease free survival drug effect drug potentiation gene expression human inflammation liver cell carcinoma liver fibrosis liver injury liver resection metastasis metastatic colorectal cancer nonhuman Note overall survival priority journal protein expression randomized controlled trial (topic) risk reduction thrombocyte treatment outcome upregulation animal liver tumor metabolism pathology Animals Antineoplastic Agents Aspirin Humans Liver Neoplasms
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174416
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174416
record_format	dspace
spelling	sg-nus-scholar.10635-1744162020-09-06T15:54:45Z Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer Xia H. Hui K.M. DUKE-NUS MEDICAL SCHOOL acetylsalicylic acid chemokine clopidogrel growth arrest and DNA damage inducible protein 45 long chain fatty acid coenzyme A ligase long chain fatty acid coenzyme A ligase 4 nonsteroid antiinflammatory agent oxidoreductase protein HTATIP2 sorafenib stromal cell derived factor 1 alpha unclassified drug acetylsalicylic acid antineoplastic agent antineoplastic activity bleeding cancer adjuvant therapy cancer prevention cancer recurrence cancer risk chronic hepatitis B chronic liver disease disease course disease free survival drug effect drug potentiation gene expression human inflammation liver cell carcinoma liver fibrosis liver injury liver resection metastasis metastatic colorectal cancer nonhuman Note overall survival priority journal protein expression randomized controlled trial (topic) risk reduction thrombocyte treatment outcome upregulation animal liver tumor metabolism pathology Animals Antineoplastic Agents Aspirin Humans Liver Neoplasms 10.1038/cddis.2017.513 Cell Death and Disease 8 10 e3112 2020-09-04T03:38:46Z 2020-09-04T03:38:46Z 2017 Article Xia H., Hui K.M. (2017). Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer. Cell Death and Disease 8 (10) : e3112. ScholarBank@NUS Repository. https://doi.org/10.1038/cddis.2017.513 2041-4889 https://scholarbank.nus.edu.sg/handle/10635/174416 Nature Publishing Group Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
topic	acetylsalicylic acid chemokine clopidogrel growth arrest and DNA damage inducible protein 45 long chain fatty acid coenzyme A ligase long chain fatty acid coenzyme A ligase 4 nonsteroid antiinflammatory agent oxidoreductase protein HTATIP2 sorafenib stromal cell derived factor 1 alpha unclassified drug acetylsalicylic acid antineoplastic agent antineoplastic activity bleeding cancer adjuvant therapy cancer prevention cancer recurrence cancer risk chronic hepatitis B chronic liver disease disease course disease free survival drug effect drug potentiation gene expression human inflammation liver cell carcinoma liver fibrosis liver injury liver resection metastasis metastatic colorectal cancer nonhuman Note overall survival priority journal protein expression randomized controlled trial (topic) risk reduction thrombocyte treatment outcome upregulation animal liver tumor metabolism pathology Animals Antineoplastic Agents Aspirin Humans Liver Neoplasms
spellingShingle	acetylsalicylic acid chemokine clopidogrel growth arrest and DNA damage inducible protein 45 long chain fatty acid coenzyme A ligase long chain fatty acid coenzyme A ligase 4 nonsteroid antiinflammatory agent oxidoreductase protein HTATIP2 sorafenib stromal cell derived factor 1 alpha unclassified drug acetylsalicylic acid antineoplastic agent antineoplastic activity bleeding cancer adjuvant therapy cancer prevention cancer recurrence cancer risk chronic hepatitis B chronic liver disease disease course disease free survival drug effect drug potentiation gene expression human inflammation liver cell carcinoma liver fibrosis liver injury liver resection metastasis metastatic colorectal cancer nonhuman Note overall survival priority journal protein expression randomized controlled trial (topic) risk reduction thrombocyte treatment outcome upregulation animal liver tumor metabolism pathology Animals Antineoplastic Agents Aspirin Humans Liver Neoplasms Xia H. Hui K.M. Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
description	10.1038/cddis.2017.513
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Xia H. Hui K.M.
format	Article
author	Xia H. Hui K.M.
author_sort	Xia H.
title	Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
title_short	Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
title_full	Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
title_fullStr	Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
title_full_unstemmed	Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
title_sort	emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
publisher	Nature Publishing Group
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174416
_version_	1681101752702599168

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer

Similar Items